The two companies aim to collaborate on solutions providing early warnings, enabling the identification of patients that could otherwise go undiagnosed.
Leading biopharmaceutical organizations join Project Baseline initiative to engage more patients and clinicians in research and speed evidence generation.
The two companies have initiated the medication adherence project and announced plans to offer Onduo virtual diabetes program to Walgreens employees.
The research study called Aurora is trying to figure out what biomarkers connect a traumatic event to the development and eventual diagnosis of PTSD.
The study will be launched with a bold goal to expand our knowledge about what human health looks like.
Compared to currently available wearables, Verily's device offers scalable collection of complex datasets across clinical and observational studies.
Temasek will help Verily expand its programs outside of the United States.
The company's Connectivity Bridge will be able to collect data from such devices as blood pressure and glucose monitors, as well as other sensors.
The two parties will establish a new company, Verb Surgical, that aims to create smaller, smarter and more affordable robotic-assisted systems for surgery.
The company will seek to answer the following question - How can we use technology to create a true picture of human health?